Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 218

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 218
---
 offering price on each of the Class A Ordinary Shares being offered. The underwriters propose
initially to offer the Class A Ordinary Shares to the public at the offering price set forth on the cover page of this prospectus and
to dealers at those prices less the aforesaid fee (“underwriting discount”) set forth on the cover page of this prospectus.
If all of the Class A Ordinary Shares offered by us are not sold at the offering price, the underwriters may change the offering price
and other selling terms by means of a supplement to this prospectus.

The following table shows the per share and total
IPO price, underwriting discounts, proceeds before expenses to us:

|                                                                                                   |     | Per      
 Ordinary 
 Share    |       |     | Total without  
 exercise of    
 over-allotment 
 option         |           |     | Total with     
 full exercise  
 of             
 over-allotment 
 option         |           |
|:--------------------------------------------------------------------------------------------------|:----|:---------|------:|:----|:---------------|----------:|:----|:---------------|----------:|
| Initial public offering price (the midpoint of                                                    
 the estimated initial public offering price range set forth on the cover page of this prospectus) |     | $        |  5.00 |     | $              | 6,250,000 |     |                | 7,187,500 |
| Underwriting discounts (7.5%)                                                                     |     | $        | 0.375 |     | $              |   468,750 |     |                |   539,063 |
| Proceeds, before expenses, to us                                                                  |     | $        | 4.625 |     | $              | 5,781,250 |     |                | 6,648,438 |

| (1) | We                                                                                                                               
 have agreed to pay the underwriters a discount equal to seven and half percent (7.5%) of the gross proceeds of this offering and 
 each closing of the over-allotment option (if any).                                                                              |

<div align='center'>123</div>

We have agreed to pay the underwriters a non-accountable
expense allowance in the amount equal to one percent (1%) of the gross proceeds of this offering.

We agreed to reimburse the underwriters for
reasonable out-of-pocket accountable expenses of no more than $200,000. In addition, we have agreed to pay Revere Securities LLC (“Revere”)
a